72065-003 : Recorlev 150 mg Oral Tablet


NDC: 72065-003
Labeler: Xeris Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Recorlev
Dosage Form: Oral Tablet
Application #: NDA214133
Rev. Date: 


NDC Package Codes:

  • 72065-003-01: 50 TABLET IN 1 BOTTLE (72065‑003‑01)

Active Ingredients:

  • Levoketoconazole

Dosage Strength:

  • 150 mg

Pharmaceutical Classes:

  • Cortisol Synthesis Inhibitor [EPC]
  • Cytochrome P450 11A1 Inhibitors [MoA]
  • Cytochrome P450 11B1 Inhibitors [MoA]
  • Cytochrome P450 17A1 Inhibitors [MoA]
  • Cytochrome P450 2B6 Inhibitors [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
  • Organic Cation Transporter 2 Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 72065-003 QR Code

< Prev: 72065-002Next: 72065-120 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.